Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Richard

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Journal of Medical Ethics|August 17, 2021
Selecting the target population for new Alzheimer drugs: challenges and expectationsEdo Richard
Nature Reviews. Neurology|February 19, 2014
Dementia: Mild cognitive impairment--not always what it seemsEdo Richard, Carol Brayne
Journal of Alzheimer'S Disease : JAD|July 16, 2019
Prevention of Cognitive Decline: A Goal in Sight?Carol Brayne, Edo Richard
BMJ (Clinical Research Ed.)|April 30, 2026
Innovation in Alzheimer's disease needs more than pharmaceutical solutionsCarol Brayne, Edo Richard
Journal of Parkinson'S Disease|November 28, 2022
Monoclonal Antibodies in Neurodegenerative Disease May Work, But They Don't Help: A Perspective from PhysiciansEdo Richard, Bastiaan R Bloem
BMJ (Clinical Research Ed.)|January 8, 2025
Challenges associated with the development of "trial ready cohorts" for dementia prevention trialsRichard Milne, Edo Richard, Carol Brayne
Bioethics|October 11, 2018
On the reconceptualization of Alzheimer's diseaseMaartje H N Schermer, Edo Richard
BMJ (Clinical Research Ed.)|November 18, 2010
Alzheimer’s disease/syndrome?. There are two types of diseaseEdo Richard, Willem A Van Gool
Handbook of Clinical Neurology|September 24, 2008
Primary central nervous system lymphomaEdo Richard, Matthijs C Brouwer, Peter Portegies
Nederlands Tijdschrift Voor Geneeskunde|November 27, 2019
[Considerable diagnostic variation among memory clinics - is it an issue?]Eric P Moll van Charante, Edo Richard
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Journal of Medical Ethics|August 17, 2021
Selecting the target population for new Alzheimer drugs: challenges and expectationsEdo Richard
Nature Reviews. Neurology|February 19, 2014
Dementia: Mild cognitive impairment--not always what it seemsEdo Richard, Carol Brayne
Journal of Alzheimer'S Disease : JAD|July 16, 2019
Prevention of Cognitive Decline: A Goal in Sight?Carol Brayne, Edo Richard
BMJ (Clinical Research Ed.)|April 30, 2026
Innovation in Alzheimer's disease needs more than pharmaceutical solutionsCarol Brayne, Edo Richard
Journal of Parkinson'S Disease|November 28, 2022
Monoclonal Antibodies in Neurodegenerative Disease May Work, But They Don't Help: A Perspective from PhysiciansEdo Richard, Bastiaan R Bloem
BMJ (Clinical Research Ed.)|January 8, 2025
Challenges associated with the development of "trial ready cohorts" for dementia prevention trialsRichard Milne, Edo Richard, Carol Brayne
Bioethics|October 11, 2018
On the reconceptualization of Alzheimer's diseaseMaartje H N Schermer, Edo Richard
BMJ (Clinical Research Ed.)|November 18, 2010
Alzheimer’s disease/syndrome?. There are two types of diseaseEdo Richard, Willem A Van Gool
Handbook of Clinical Neurology|September 24, 2008
Primary central nervous system lymphomaEdo Richard, Matthijs C Brouwer, Peter Portegies
Nederlands Tijdschrift Voor Geneeskunde|November 27, 2019
[Considerable diagnostic variation among memory clinics - is it an issue?]Eric P Moll van Charante, Edo Richard
Pageof 20